1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model
- Contribution to journal › Article
-
Mark
An optimised Bcl-3 inhibitor for melanoma treatment
- Contribution to journal › Article
- 2024
-
Mark
AGREE II Quality Assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by the OPTIMA Consortium
- Contribution to journal › Scientific review
-
Mark
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer : Big Data Analytics Using the PIONEER Platform
- Contribution to journal › Article
- 2023
-
Mark
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
- Contribution to journal › Article
- 2021
-
Mark
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
- Contribution to journal › Article
-
Mark
Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
(2021) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 62(7). p.989-995
- Contribution to journal › Article
- 2020
-
Mark
Introducing PIONEER : a project to harness big data in prostate cancer research
- Contribution to journal › Article
-
Mark
Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study
- Contribution to journal › Article
- 2019
-
Mark
Preserving Preclinical PET Quality During Intratherapeutic Imaging in Radionuclide Therapy with Rose Metal Shielding Reducing Photon Flux
- Contribution to journal › Article
